BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26911608)

  • 1. Acyclovir-induced bullous reaction in a patient with metastatic breast cancer.
    Yorulmaz A; Sahin EB; Sener M; Kulcu Cakmak S
    Cutan Ocul Toxicol; 2017 Mar; 36(1):85-87. PubMed ID: 26911608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Localized bullous eruption after intravenous injection of aciclovir: toxic or immunoallergic mechanism?].
    Armingaud P; Arsac P; Kerdraon R; Esteve E
    Ann Dermatol Venereol; 2000 May; 127(5):496-8. PubMed ID: 10863180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergic drug eruption secondary to intravenous acyclovir.
    Schuster J; Fabri M; Eming S; Hunzelmann N
    Acta Derm Venereol; 2008; 88(2):196-8. PubMed ID: 18311465
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug eruption secondary to aciclovir with recall phenomenon in a dermatome previously affected by herpes zoster.
    Carrasco L; Pastor MA; Izquierdo MJ; Fariña MC; Martín L; Fortes J; Requena L
    Clin Exp Dermatol; 2002 Mar; 27(2):132-4. PubMed ID: 11952706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which term should be used to describe drug eruptions confined to sites of previous herpes zoster lesions, 'isotopic response' or 'recall phenomenon'?
    Mizukawa Y; Shiohara T
    Clin Exp Dermatol; 2004 May; 29(3):323; author reply 324. PubMed ID: 15115529
    [No Abstract]   [Full Text] [Related]  

  • 6. Localized bullous eruptions away from infusion site due to intravenous acyclovir administration in a child.
    Gurkan A; Erkek N; Senel S
    Indian J Pharmacol; 2012 Jan; 44(1):126-8. PubMed ID: 22345887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A patient with thyroid carcinoma who developed consciousness disturbance during acyclovir administration for herpes zoster].
    Matsumoto R; Yoshida T; Tabata K; Nakagawa S; Yanagisawa N
    Rinsho Shinkeigaku; 1996 Apr; 36(4):590-3. PubMed ID: 8810856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vesicular eruptions following acyclovir administration.
    Buck ML; Vittone SB; Zaglul HF
    Ann Pharmacother; 1993 Dec; 27(12):1458-9. PubMed ID: 8305776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acyclovir nephrotoxicity].
    Briso-Montiano JM; Hernández E; Escudero E; Mendiluce A; Sánchez L; Miyar V
    An Med Interna; 1995 Oct; 12(10):501-2. PubMed ID: 8519942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the mailing list: use of acyclovir in patients on hemodialysis].
    D'Amico M; Fraticelli M; Limido A
    G Ital Nefrol; 2005; 22(1):66-9. PubMed ID: 15786379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symmetrical drug-related intertriginous and flexural exanthema caused by valacyclovir.
    Daito J; Hanada K; Katoh N; Katoh S; Sakamoto K; Asai J; Takenaka H; Kishimoto S
    Dermatology; 2009; 218(1):60-2. PubMed ID: 18974630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered mental status from acyclovir.
    Martinez-Diaz GJ; Hsia R
    J Emerg Med; 2011 Jul; 41(1):55-8. PubMed ID: 19926428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute renal failure with acyclovir treatment in a child with leukemia.
    Genc G; Ozkaya O; Acikgöz Y; Yapici O; Bek K; Gülnar Sensoy S; Ozyürek E
    Drug Chem Toxicol; 2010 Apr; 33(2):217-9. PubMed ID: 20307148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Delirium during oral therapy of herpes zoster with acyclovir. Case report and brief review of central nervous system side-effects of acyclovir].
    Braun JS; Apel I; Schäffer S; Schumacher M; Berger M
    Nervenarzt; 1998 Nov; 69(11):1015-8. PubMed ID: 9859124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotoxicity induced by the recommended acyclovir dosing in a dialysis patient with herpes zoster: A case letter.
    Kageyama R; Hashizume H
    J Dermatol; 2016 Mar; 43(3):339-40. PubMed ID: 26589129
    [No Abstract]   [Full Text] [Related]  

  • 16. Disseminated cutaneous herpes zoster complicated by acyclovir nephrotoxicity and successfully treated with brivudin.
    Aksoy B; Altaykan-Hapa A; Cengiz A; Mete Aksoy H; Atakan N
    Eur J Dermatol; 2010; 20(2):247-8. PubMed ID: 20103497
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurotoxicity associated with acyclovir in end stage renal failure.
    Kitching AR; Fagg D; Hay NM; Hatfield PJ; Macdonald A
    N Z Med J; 1997 May; 110(1043):167-9. PubMed ID: 9196501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rare case of acyclovir-induced thrombocytopenia.
    Kamboj J; Wu F; Kamboj R; Suzue K; Khosla P
    Am J Ther; 2014; 21(5):e159-62. PubMed ID: 23344109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster.
    Lin WR; Lin HH; Lee SS; Tsai HC; Huang CK; Wann SR; Chen YS; Chiang SC; Yen MY; Liu YC
    J Microbiol Immunol Infect; 2001 Jun; 34(2):138-42. PubMed ID: 11456360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral edema and oral acyclovir.
    Hisler BM; Daneshvar SA; Aronson PJ; Hashimoto K
    J Am Acad Dermatol; 1988 May; 18(5 Pt 1):1142-3. PubMed ID: 2968376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.